Skip to main content

Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

J.P. Morgan Lowers ABT Target To $55 From $60

BenzingaStaffL  
January 27, 2011 7:39am   Comments
Share:

J.P. Morgan is lowering its PT on Abbott Laboratories (NYSE: ABT) to $55 from $60.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

 

Related Articles (ABT)

This New ETF Brings Out The Best In S&P 500 Without The Tech Overload
Looking Into Abbott Laboratories's Recent Short Interest
These Analysts Revise Their Forecasts On Abbott Following Q2 Results
Microsoft To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday
P/E Ratio Insights for Abbott Laboratories
Nasdaq 100 Sets New Records, Small Caps Outperform: What's Moving Markets Thursday?
View Comments and Join the Discussion!

Posted-In: abbott laboratories J.P. MorganAnalyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com